Observational studyPloS one2025

Evaluating liver type fatty acid binding protein as a diagnostic and prognostic biomarker in metabolic dysfunction-associated steatotic liver disease in pediatric patients.

Nadia Al Mazrouei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.